• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

vaccines - Articles and news items


How Panacea is paving the way for vaccine immunotherapies

Blog, Z Homepage promo / 29 March 2017 / Niamh Marriott, Junior Editor

We caught up with the CEO & CSO of Panacea for the latest on vaccine immunotherapies – “As a scientist, as long as you are observant and persistent, you may come up with breakthrough discoveries”

Sanofi Pasteur and MSD end joint vaccines business in Europe

Industry news / 3 January 2017 / Niamh Louise Marriott, Digital Editor

Sanofi and its vaccines business unit Sanofi Pasteur will end their vaccine joint-venture with MSD (known as Merck in the US and Canada) – SPMSD…

BARDA grants Sanofi $43.2 million for Zika vaccine development

Industry news / 27 September 2016 / Niamh Louise Marriott, Digital Content Producer

In July, Sanofi revealed the development agreement with the Walter Reed Army Institute of Research on the co-development of a Zika vaccine candidate…

Sanofi sends half a million dengue vaccines to high risk Brazilians

Industry news / 15 August 2016 / Sanofi

Results of the study affirm the vaccine’s consistent efficacy in reducing dengue in two-thirds of the study participants, aged 9 and older. It also documents the ability of the vaccine to prevent 8 out of 10 hospitalisations and up to 93% of severe dengue cases in this age group during the 25 month follow-up phase of the studies…

Scientists develop cost-effective electricity-free vaccine cooler

Industry news / 6 July 2016 / Victoria White, Digital Content Producer

Scientists have developed a cost-effective vaccine cooler which preserves vaccines for 35 days using just 30 litres of ice and without needing electricity…